ABBV logo

AbbVie (ABBV)

Profile

Full Name

AbbVie Inc.

Ticker Symbol

ABBV

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

United States

IPO

January 2, 2013

Indexes

S&P 500

Website

http://www.abbvie.com

Employees

55000

Key Details

Price

$181.80(-1.65%)

Market cap

$321.13B(Mega cap)

Last Dividend

$1.64

TTM Dividend yield

3.51%

Annual revenue

$56.33B(+3.71% YoY)

Annual EPS

$2.39(-12.13% YoY)

PE ratio

77.36

Next earnings date

Jul 25, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $181.80
    ABBV price is $181.80

    30-Day Relative Volume

    0.38
    ABBV 30-day relative volume is 0.38

    Price Performance

    Price Today change

    -1.65%
    ABBV price is down -1.65% today

    Price YTD change

    +2.31%
    ABBV price is up +2.31% since January 1st

    Price 1-year change

    +11.58%
    ABBV price is up +11.58% year-on-year

    Price 3-year change

    +20.39%
    ABBV price is up +20.39% over the past 3 years

    Price Range

    Price All-time high

    $218.66
    ABBV price is currently -16.86% below its historical high of $218.66

    Price 3-year low

    $130.96
    ABBV price is currently +38.82% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $321.13B
    ABBV market capitalization is $321.13 billion

    Market cap 3-year change

    +20.34%
    ABBV market capitalization is up +20.34% over the past 3 years

    Market cap All-time high

    $383.27B
    ABBV market capitalization is currently -16.21% below its historical high of $383.27 billion

    Market cap sector rank

    99.84%
    ABBV market capitalization is higher than 99.84% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.03%
    ABBV shares outstanding is up +0.03% year-on-year

    Shares Outstanding 3-Year Change

    -0.04%
    ABBV shares outstanding is down -0.04% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.37
    ABBV beta is 0.37

    200-day SMA

    $189.26
    ABBV price is currently -3.94% below its 200-day simple moving average

    50-day SMA

    $191.89
    ABBV price is currently -5.26% below its 50-day simple moving average

    RSI

    44.43
    ABBV 14-day relative strength index is 44.43

    Volume

    0.38
    ABBV 30-day relative volume is 0.38

    ATR

    $5.50
    ABBV average true range is $5.50

    10-day Historical Volatility

    38.86%
    ABBV 10-day historical volatility is 38.86%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $1.64
    ABBV last dividend was $1.64 per share, with an ex-dividend date of April 15, 2025

    Next Dividend

    -
    ABBV next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $6.20
    ABBV annual dividend per share is $6.20

    Dividend per share Sector Rank

    94.19%
    ABBV annual dividend per share is higher than 94.19% of companies in Healthcare sector

    Dividend per share 1-Year Change

    +4.73%
    ABBV annual dividend per share is up +4.73% year-on-year

    Dividend per share 3-Year Change

    +19.23%
    ABBV annual dividend per share is up +19.23% over the past 3 years

    Dividend yield

    Dividend yield

    3.41%
    ABBV annual dividend yield is 3.41%

    Dividend yield Sector Rank

    69.41%
    ABBV annual dividend yield is higher than 69.41% of companies in Healthcare sector

    Other

    Payout ratio

    257.71%
    ABBV annual payout ratio is 257.71%

    Dividends paid

    $11.03B
    ABBV annual dividends paid is $11.03 billion

    Free cash flow

    $17.83B
    ABBV annual free cash flow is $17.83 billion

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $56.33B
    ABBV annual revenue is $56.33 billion

    Revenue Analysts estimate

    $59.91B
    ABBV annual revenue is currently -5.98% lower than the consensus analysts' forecast

    Revenue 1-year change

    +3.71%
    ABBV annual revenue is up +3.71% year-on-year

    Revenue Sector rank

    98.42%
    ABBV annual revenue is higher than 98.42% of companies in Healthcare sector

    EPS

    EPS

    $2.39
    ABBV annual earnings per share is $2.39

    EPS Analysts estimate

    $12.23
    ABBV annual earnings per share is currently -80.45% lower than the consensus analysts' forecast

    EPS 1-year change

    -12.13%
    ABBV annual earnings per share is down -12.13% year-on-year

    EPS Sector rank

    93%
    ABBV annual earnings per share is higher than 93% of companies in Healthcare sector

    Profit

    Gross profit

    $39.43B
    ABBV annual gross profit is $39.43 billion

    Gross margin

    69.99%
    ABBV annual gross profit margin is 69.99%

    Operating profit

    $9.14B
    ABBV annual operating income is $9.14 billion

    Operating margin

    16.22%
    ABBV annual operating profit margin is 16.22%

    Net income

    $4.28B
    ABBV annual net profit is $4.28 billion

    Net margin

    7.59%
    ABBV annual net profit margin is 7.59%

    Expenses

    Total expenses

    $47.20B
    ABBV annual total expenses is $47.20 billion

    Operating expenses

    $30.29B
    ABBV annual total operating expenses is $30.29 billion

    Cost of goods sold

    $16.90B
    ABBV annual cost of goods sold is $16.90 billion

    Selling, general & administrative expenses

    $14.75B
    ABBV annual SGA is $14.75 billion

    Depreciation and amortization

    $8.39B
    ABBV annual depreciation & amortization is $8.39 billion

    Interest expense

    $2.81B
    ABBV annual interest expense is $2.81 billion

    Income tax

    -$570.00M
    ABBV annual income tax is -$570.00 million

    EBIT & EBITDA

    EBIT

    $9.14B
    ABBV annual earnings before interest & taxes is $9.14 billion

    EBITDA

    $9.14B
    ABBV annual EBITDA is $9.14 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $135.16B
    ABBV annual total assets is $135.16 billion

    Non current assets

    $109.58B
    ABBV annual long term assets is $109.58 billion

    Current assets

    $25.58B
    ABBV annual total current assets is $25.58 billion

    Cash and cash equivalents

    $5.52B
    ABBV annual cash & cash equivalents is $5.52 billion

    Accounts receivable

    $10.92B
    ABBV annual accounts receivable is $10.92 billion

    Inventory

    $4.18B
    ABBV annual inventory is $4.18 billion

    Liabilities

    Total liabilities

    $131.80B
    ABBV annual total liabilities is $131.80 billion

    Long term liabilities

    $93.05B
    ABBV annual total long term liabilities is $93.05 billion

    Current liabilities

    $38.75B
    ABBV annual total current liabilities is $38.75 billion

    Accounts payable

    $2.94B
    ABBV annual accounts payable is $2.94 billion

    Debt

    Total debt

    $67.14B
    ABBV annual total debt is $67.14 billion

    Total debt 1-year change

    +13.07%
    ABBV annual total debt is up +13.07% year-on-year

    Long term debt

    $60.34B
    ABBV annual long term debt is $60.34 billion

    Short term debt

    $6.80B
    ABBV annual short term debt is $6.80 billion

    Equity & Capital

    Shareholders equity

    $3.33B
    ABBV annual stockholders equity is $3.33 billion

    Book value

    $3.33B
    ABBV annual book value is $3.33 billion

    Retained earnings

    -$7.90B
    ABBV annual retained earnings is -$7.90 billion

    Working capital

    -$13.17B
    ABBV annual working capital is -$13.17 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $18.81B
    ABBV annual cash flow from operations is $18.81 billion

    Cash from operations 1-year change

    -17.66%
    ABBV annual cash flow from operations is down -17.66% year-on-year

    Cash from investing

    -$20.82B
    ABBV annual cash flow from investing activities is -$20.82 billion

    Cash from investing 1-year change

    -936.34%
    ABBV annual cash flow from investing activities is down -936.34% year-on-year

    Cash from financing

    -$5.21B
    ABBV annual cash flow from financing activities is -$5.21 billion

    Cash from financing 1-year change

    +69.74%
    ABBV annual cash flow from financing activities is up +69.74% year-on-year

    CAPEX

    CAPEX

    $974.00M
    ABBV annual capital expenditures is $974.00 million

    CAPEX 1-year change

    +25.35%
    ABBV annual capital expenditures is up +25.35% year-on-year

    Free Cash Flow

    Free cash flow

    $17.83B
    ABBV annual free cash flow is $17.83 billion

    Free cash flow 1-year change

    -19.17%
    ABBV annual free cash flow is down -19.17% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    69.99%
    ABBV annual gross profit margin is 69.99%

    Operating margin

    16.22%
    ABBV annual operating profit margin is 16.22%

    Net margin

    7.59%
    ABBV annual net profit margin is 7.59%

    ROA & ROE

    ROA

    3.17%
    ABBV annual return on assets is 3.17%

    ROE

    62.18%
    ABBV annual return on equity is 62.18%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    77.36
    ABBV price to earnings ratio is 77.36

    PE ratio Sector rank

    90.91%
    ABBV price to earnings ratio is higher than 90.91% of companies in Healthcare sector

    PB Ratio

    PB ratio

    226.15
    ABBV price to book ratio is 226.15

    PB ratio Sector rank

    99.67%
    ABBV price to book ratio is higher than 99.67% of companies in Healthcare sector

    PS Ratio

    PS ratio

    5.60
    ABBV price to sales ratio is 5.60

    PS ratio Sector rank

    66.92%
    ABBV price to sales ratio is higher than 66.92% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $385.85B
    ABBV enterprise value is $385.85 billion

    Enterprise value Sector rank

    99.91%
    ABBV enterprise value is higher than 99.91% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    30.36
    ABBV EV/EBITDA is 30.36

    EV/EBITDA Sector rank

    94.37%
    ABBV EV/EBITDA is higher than 94.37% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.66
    ABBV annual current ratio is 0.66

    Quick ratio

    0.55
    ABBV annual quick ratio is 0.55

    Leverage

    Debt to equity

    20.19
    ABBV annual debt to equity ratio is 20.19

    Interest coverage ratio

    3.25
    ABBV annual interest coverage ratio is 3.25

    Risk & Stability

    Piotroski F-Score

    7
    ABBV piotroski f-score is 7

    Altman Z-Score

    1.90
    ABBV altman z-score is 1.90

    Analyst ratings

    Recent major analysts updates

    Apr 29, 25 Guggenheim
    Buy
    Apr 28, 25 Morgan Stanley
    Overweight
    Apr 28, 25 Evercore ISI Group
    Outperform
    Apr 22, 25 Cantor Fitzgerald
    Overweight
    Apr 17, 25 Guggenheim
    Buy
    Apr 9, 25 Morgan Stanley
    Overweight
    Mar 5, 25 Wells Fargo
    Overweight
    Mar 4, 25 B of A Securities
    Neutral
    Feb 3, 25 Wells Fargo
    Overweight
    Feb 3, 25 UBS
    Neutral

    Institutional Ownership

    Screeners with ABBV included

    Highest dividend in sector
    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 5 years
    S&P 500 companies
    Stocks below analysts price target
    • What is the ticker symbol for AbbVie?
    • Does AbbVie pay dividends?
    • What sector is AbbVie in?
    • What industry is AbbVie in?
    • What country is AbbVie based in?
    • When did AbbVie go public?
    • Is AbbVie in the S&P 500?
    • Is AbbVie in the NASDAQ 100?
    • Is AbbVie in the Dow Jones?
    • When was AbbVie's last earnings report?
    • When does AbbVie report earnings?
    • Should I buy AbbVie stock now?

    What is the ticker symbol for AbbVie?

    The ticker symbol for AbbVie is NYSE:ABBV

    Does AbbVie pay dividends?

    Yes, AbbVie pays dividends. The last payment was $1.64, with an ex-dividend date on April 15, 2025

    What sector is AbbVie in?

    AbbVie is in the Healthcare sector

    What industry is AbbVie in?

    AbbVie is in the Drug Manufacturers - General industry

    What country is AbbVie based in?

    AbbVie is headquartered in United States

    When did AbbVie go public?

    AbbVie's initial public offering (IPO) was on January 2, 2013

    Is AbbVie in the S&P 500?

    Yes, AbbVie is included in the S&P 500 index

    Is AbbVie in the NASDAQ 100?

    No, AbbVie is not included in the NASDAQ 100 index

    Is AbbVie in the Dow Jones?

    No, AbbVie is not included in the Dow Jones index

    When was AbbVie's last earnings report?

    AbbVie's most recent earnings report was on Apr 25, 2025

    When does AbbVie report earnings?

    The next expected earnings date for AbbVie is Jul 25, 2025

    Should I buy AbbVie stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page